Douglass Winthrop Advisors LLC Sells 300 Shares of Encompass Health Co. (NYSE:EHC)

Douglass Winthrop Advisors LLC reduced its stake in Encompass Health Co. (NYSE:EHC) by 8.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,300 shares of the company’s stock after selling 300 shares during the period. Douglass Winthrop Advisors LLC’s holdings in Encompass Health were worth $319,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Harbor Capital Advisors Inc. raised its position in shares of Encompass Health by 275.7% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 35,799 shares of the company’s stock worth $3,071,000 after acquiring an additional 26,270 shares in the last quarter. QRG Capital Management Inc. raised its holdings in Encompass Health by 85.6% in the second quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock worth $1,232,000 after purchasing an additional 6,627 shares in the last quarter. SG Americas Securities LLC purchased a new position in Encompass Health during the second quarter valued at $2,204,000. Los Angeles Capital Management LLC boosted its holdings in shares of Encompass Health by 532.4% during the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after buying an additional 42,338 shares in the last quarter. Finally, Kennedy Capital Management LLC grew its position in shares of Encompass Health by 19.6% in the 1st quarter. Kennedy Capital Management LLC now owns 99,720 shares of the company’s stock worth $8,235,000 after buying an additional 16,318 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

EHC has been the topic of several research reports. Barclays boosted their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 29th. Truist Financial reissued a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Stephens reaffirmed an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. Royal Bank of Canada boosted their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Finally, KeyCorp lifted their price target on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Price Performance

NYSE EHC opened at $102.00 on Tuesday. Encompass Health Co. has a one year low of $63.78 and a one year high of $104.55. The stock has a 50-day moving average of $97.28 and a 200 day moving average of $90.99. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. The company has a market capitalization of $10.28 billion, a price-to-earnings ratio of 24.64, a PEG ratio of 1.34 and a beta of 0.88.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The business’s revenue for the quarter was up 11.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.86 earnings per share. On average, sell-side analysts forecast that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be paid a $0.17 dividend. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.67%. Encompass Health’s dividend payout ratio (DPR) is currently 16.43%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.